Fenoprofen (Fenopron, Fenopron-t)
Fenoprofen
Pharmacare limited û woodmead
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fenopron 300 EACH CAPSULE CONTAINS FENOPROFEN CALCIUM EQUIVALENT TO 300 mg FENOPROFEN | 300 | F0092F/3.2/92 | Cancelled | Not determined | None |
| Fenopron-t EACH TABLET CONTAINS FENOPROFEN CALCIUM EQUIVALENT TO FENOPROFEN 600 mg | Not listed | H0097H/3.2/97 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S3: Fenoprofen
- except when intended for the emergency treatment of acute gout attacks, (S2) and
- when intended for the treatment of post traumatic conditions, for a maximum treatment period of 5 days. (S2)
Consolidated Schedules 06 July 2026, lines 3569 to 3574
S2: Fenoprofen
- when intended for the emergency treatment of acute gout attacks, and
- when intended for the treatment of post-traumatic conditions, for a maximum treatment period of 5 days. (S3)
Consolidated Schedules 06 July 2026, lines 1971 to 1982
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-(3-Phenoxyphenyl)propanoic acid
Drag to rotate. Structure from PubChem CID 3342.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.